
Josep M. Llovet
Featured publications
-
Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma
Authors: Haber PK; Castet F; Torres-Martin M; Andreu-Oller C; Puigvehí M; Miho M; Radu P; Dufour JF; Verslype C; Czauderna C; Marquardt JU; Galle PR; Vogel A; Bathon M; Meyer T; Labgaa I; Digklia A; Roberts LR; Mohamed Ali MA; Mínguez B; Citterio D; Mazzaferro V; Finkelmeier F; Trojan J; Özdirik B; Müller T; Schmelzle M; Bejjani A; Sung MW; Schwartz ME; Finn RS; Thung S; Villanueva A; Sia D; Llovet JM.Reference: Gastroenterology 2023. -
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
Authors: Montironi C, Castet F, Haber PK, Pinyol R, Torres-Martin M, Torrens L, Mesropian A, Wang H, Puigvehi M, Maeda M, Leow WQ, Harrod E, Taik P, Chinburen J, Taivanbaatar E, Chinbold E, Solé Arqués M, Donovan M, Thung S, Neely J, Mazzaferro V, Anderson J, Roayaie S, Schwartz M, Villanueva A, Friedman SL, Uzilov A, Sia D, Llovet JM .Reference: Gut 2023. -
International Liver cancer Association (ILCA) White Paper on Hepatocellular carcinoma Risk Stratification and Surveillance
Authors: Singal AG; Sanduzzi-Zamparelli M; Nahon P; Ronot M; Hoshida Y; Rich N; Reig M; Vilgrain V; Marrero J; Llovet JM; Parikh ND; Villanueva A.Reference: Journal Of Hepatology 2023. -
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Authors: Llovet JM; Willoughby CE; Singal AG; Greten TF; Heikenwälder M; El-Serag HB; Finn RS; Friedman SL.Reference: Nature Reviews Gastroenterology & Hepatology 2023. -
Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Authors: Pinyol R, Torrecilla S, Wang H, Montironi C, Piqué-Gili M, Torres-Martin M, Wei-Qiang L, Willoughby CE, Ramadori P, Andreu-Oller C, Taik P, Lee YA, Moeini A, Peix J, Faure-Dupuy S, Riedl T, Schuehle S, Oliveira CP, Alves VA, Boffetta P, Lachenmayer A, Roessler S, Minguez B, Schirmacher P, Dufour JF, Thung SN, Reeves HL, Carrilho FJ, Chang C, Uzilov AV, Heikenwalder M, Sanyal A, Friedman SL, Sia D, Llovet JM .Reference: Journal Of Hepatology 2021. -
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Authors: Pfister, Dominik; Nunez, Nicolas Gonzalo; Pinyol, Roser; Govaere, Olivier; Pinter, Matthias; Szydlowska, Marta; Gupta, Revant; Qiu, Mengjie; Deczkowska, Aleksandra; Weiner, Assaf; Mueller, Florian; Sinha, Ankit; Friebel, Ekaterina; Engleitner, Thomas; Lenggenhager, Daniela; Moncsek, Anja; Heide, Danijela; Stirm, Kristin; Kosla, Jan; Kotsiliti, Eleni; Leone, Valentina; Dudek, Michael; Yousuf, Suhail; Inverso, Donato; Singh, Indrabahadur; Teijeiro, Ana; Castet, Florian; Montironi, Carla; Haber, Philipp K.; Tiniakos, Dina; Bedossa, Pierre; Cockell, Simon; Younes, Ramy; Vacca, Michele; Marra, Fabio; Schattenberg, Jorn M.; Allison, Michael; Bugianesi, Elisabetta; Ratziu, Vlad; Pressiani, Tiziana; D'Alessio, Antonio; Personeni, Nicola; Rimassa, Lorenza; Daly, Ann K.; Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M.; Vogel, Arndt; Peck-Radosavljevic, Markus; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Trojan, Jorg; Schulze, Kornelius; Wege, Henning; Koch, Sandra; Weinmann, Arndt; Bueter, Marco; Rossler, Fabian; Siebenhuner, Alexander; De Dosso, Sara; Mallm, Jan-Philipp; Umansky, Viktor; Jugold, Manfred; Luedde, Tom; Schietinger, Andrea; Schirmacher, Peter; Emu, Brinda; Augustin, Hellmut G.; Billeter, Adrian; Mueller-Stich, Beat; Kikuchi, Hiroto; Duda, Dan G.; Kutting, Fabian; Waldschmidt, Dirk-Thomas; Ebert, Matthias Philip; Rahbari, Nuh; Mei, Henrik E.; Schulz, Axel Ronald; Ringelhan, Marc; Malek, Nisar; Spahn, Stephan; Bitzer, Michael; Ruiz de Galarreta, Marina; Lujambio, Amaia; Dufour, Jean-Francois; Marron, Thomas U.; Kaseb, Ahmed; Kudo, Masatoshi; Huang, Yi-Hsiang; Djouder, Nabil; Wolter, Katharina; Zender, Lars; Marche, Parice N.; Decaens, Thomas; Pinato, David J.; Rad, Roland; Mertens, Joachim C.; Weber, Achim; Unger, Kristian; Meissner, Felix; Roth, Susanne; Jilkova, Zuzana Macek; Claassen, Manfred; Anstee, Quentin M.; Amit, Ido; Knolle, Percy; Becher, Burkhard; Llovet, Josep M.; Heikenwalder, Mathias;.Reference: Nature 2021. -
Hepatocellular carcinoma
Authors: Llovet JM; Kelley RK; Villanueva A; Singal AG; Pikarsky E; Roayaie S; Lencioni R; Koike K; Zucman-Rossi J; Finn RS.Reference: Nature Reviews Disease Primers 2021. -
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Authors: Schulze K., Imbeaud S., Letouzé E., Alexandrov L.B., Calderaro J., Rebouissou S., Couchy G., Meiller C., Shinde J., Soysouvanh F., Calatayud A.L., Pinyol R., Pelletier L., Balabaud C., Laurent A., Blanc J.F., Mazzaferro V., Calvo F., Villanueva A., Nault J.C., Bioulac-Sage P., Stratton M.R., Llovet J.M., Zucman-Rossi J..Reference: Nature Genetics 2015. -
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Authors: Hoshida, Yujin; Villanueva, Augusto; Kobayashi, Masahiro; Peix, Judit; Chiang, Derek Y; Camargo, Amy; Gupta, Supriya; Moore, Jamie; Wrobel, Matthew J; Lerner, Jim; Reich, Michael; Chan, Jennifer A; Glickman, Jonathan N; Ikeda, Kenji; Hashimoto, Masaji; Watanabe, Goro; Daidone, Maria G; Roayaie, Sasan; Schwartz, Myron; Thung, Swan; Salvesen, Helga B; Gabriel, Stacey; Mazzaferro, Vincenzo; Bruix, Jordi; Friedman, Scott L; Kumada, Hiromitsu; Llovet, Josep M; Golub, Todd R.Reference: New England Journal Of Medicine 2008. -
Sorafenib in Advanced Hepatocellular Carcinoma Reply
Authors: Tabernero Caturla, Josep; Llovet, Josep M; Bruix, Jordi.Reference: New England Journal Of Medicine 2008.
Featured Projects
-
Molecular characterization of obesity/diabetes/NASH-related hepatocellular carcinoma
Principal investigator: Josep M. Llovet BayerFunder: Ministerio de Economia y Competitividad (MINECO)Code: PID2019-105378RB-100Duration: 01/01/2020 - 31/12/2023 -
HUNTER-Hepatocellular Carcinoma Expediter Network CRUK, AEDD, AIRC Accelerator Award.
Principal investigator: Josep M. Llovet BayerFunder: Asociación Española Contra el Cáncer (AECC) ; CRUK, AECC, AIRC Accelerator AwardCode: AECC-Accelerator Award 2017Duration: 01/01/2019 - 31/12/2023 -
Mecanismos de Resistencia adquirida a sorafenib en el carcinoma hepatocelular
Principal investigator: Josep M. Llovet BayerFunder: National Health Institute, Spain. I+D Program, IIBB/IDIBAPS/CSIC (Sede o evento); National Health Institute, Spain. ; IDIBAPS - Hospital Clínic (Sede o evento)Code: (Grant number: SAF2016-76390-R)Duration: 01/01/2017 - 31/12/2020 -
Laboratori de Recerca Translacional en Oncologia Hepàtica
Principal investigator: Josep M. Llovet BayerDuration: 01/01/2022 - 31/12/2024 -
Identification of biomarkers predicting response and resistance to immunotherapy in advanced hepatocellular carcinoma
Principal investigator: Josep M. Llovet BayerDuration: 01/12/2021 - 30/11/2025